Evidence map›Paper›PMID 18830402›Full record

ArticlePloS one2008

Chemical addressability of ultraviolet-inactivated viral nanoparticles (VNPs).

Chris Rae, Kristopher J Koudelka, Giuseppe Destito, Mayra N Estrada, Maria J Gonzalez, Marianne Manchester

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.3field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Materials advances · 2021
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Applications of plant viruses in bionanotechnology.Current topics in microbiology and immunology · 2014
    Review
  8. Targeted nanoparticles in imaging: paving the way for personalized medicine in the battle against cancer.Integrative biology : quantitative biosciences from nano to macro · 2013
    Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Chris RaeDepartment of Cell Biology, and Center for Integrative Molecular Biosciences, The Scripps Research Institute, La Jolla, California, USA.
Kristopher J Koudelka
Giuseppe Destito
Mayra N Estrada
Maria J Gonzalez
Marianne Manchester
Scripps Research Institute · US

Funding

USING VIRAL NANOPARTICLES TO TARGET CANCERR01CA112075 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MANCHESTER, MARIANNE · 2005 to 2009
$3.7M
NCI NIH HHS CA112075NCI NIH HHS R01 CA112075
6 · The paper itself

Abstract

backgroundCowpea Mosaic Virus (CPMV) is increasingly being used as a nanoparticle platform for multivalent display of molecules via chemical bioconjugation to the capsid surface. A growing variety of applications have employed the CPMV multivalent display technology including nanoblock chemistry, in vivo imaging, and materials science. CPMV nanoparticles can be inexpensively produced from experimentally infected cowpea plants at high yields and are extremely stable. Although CPMV has not been shown to replicate in mammalian cells, uptake in mammalian cells does occur in vitro and in vivo. Thus, inactivation of the virus RNA genome is important for biosafety considerations, however the surface characteristics and chemical reactivity of the particles must be maintained in order to preserve chemical and structural functionality. METHODOLOGY/PRINCIPAL

findingsShort wave (254 nm) UV irradiation was used to crosslink the RNA genome within intact particles. Lower doses of UV previously reported to inactivate CPMV infectivity inhibited symptoms on inoculated leaves but did not prohibit systemic virus spread in plants, whereas higher doses caused aggregation of the particles and an increase in chemical reactivity further indicating broken particles. Intermediate doses of 2.0-2.5 J/cm(2) were shown to maintain particle structure and chemical reactivity, and cellular binding properties were similar to CPMV-WT.

conclusionsThese studies demonstrate that it is possible to inactivate CPMV infectivity while maintaining particle structure and function, thus paving the way for further development of CPMV nanoparticles for in vivo applications.

Indexed as

NanoparticlesUltraviolet RaysVirus InactivationComovirus

Identifiers

PMID18830402
PMCPMC2551747
OpenAlexW2088770713

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.